Chronische Ziekten Model

Bronnen en Literatuur

Bronnen

• GPRD. The General Practice Research Database.
• NKR. Nederlandse Kanker Registratie

Literatuur

• Baal PH van, Engelfriet PM, Hoogenveen RT, Poos MJ, Dungen C van den, Boshuizen HC.Estimating and comparing incidence and prevalence of chronic diseases by combining GP registry data: the role of uncertainty. BMC Public Health, 2011; 11(Mar 15): 163.
• Baal PH van, Hoogenveen RT, Engelfriet PM, Boshuizen HC.Indirect estimation of chronic disease excess mortality. Epidemiology, 2010c; 3(May; 21): 425-6.
• Baal PHM van, Feenstra TL, Hoogenveen RT, Wit GA de. Cost Effectiveness Analysis with the RIVM Chronic Disease Model. RIVM-rapport nr. 260706002. Bilthoven: National Institute for Public Health and the Environment,2005b.
• Baal PHM van, Hoeymans N, Hoogenveen RT, Wit AG de, Westert GP.Disability weights for comorbidity and their influence on Healthy Adjusted Life Expectancy. Population Health Metric, 2006.
• Baal PHM van, Hoogenveen RT, Wit GA de, Boshuizen HC. Estimating health-adjusted life expectancy conditional on risk factors: results for smoking and obesity. Popul Health Metr,2006c; 4: 14.
• Baan CA, van Baal PH, Jacobs-van der Bruggen MA, Verkley H, Poos MJ, Hoogenveen RT, Schoemaker CG. Diabetes mellitus in Nederland: schatting van de huidige ziektelast en prognose voor 2025. [Diabetes mellitus in the Netherlands: estimate of the current disease burden and prognosis for 2025]. Ned Tijdschr Geneeskd2009c; 153(22): 1052-8
• Bemelmans W, van Baal P, Wendel-Vos W, Schuit J, Feskens E, Ament A, Hoogenveen R. The costs, effects and cost-effectiveness of counteracting overweight on a population level. A scientific base for policy targets for the Dutch national plan for action. Prev Med2008b; 46(2): 127-32
• Berg M van den, Baal PH van, Tariq L, Schuit AJ, Wit GA de, Hoogeveen RT. The cost-effectiveness of increasing alcohol taxes: a modelling study. BMC Medicine,2008b; 6(1): 36.
• Bots ML, Jager-Geurts MH, Berger-van Sijl M, Reitsma JB, Dippel DWJ van, Bruin A de.Kans op overlijden na een eerste ziekenhuisopname voor een cerebrovasculaire aandoening in Nederland. In: Jager-Geurts MH, Peters RJG, Dis SJ van, Bots ML (eds.). Hart- en vaatziekten in Nederland 2006. Cijfers over leefstijl- en risicofactoren, ziekte en Den Haag: Nederlandse Hartstichting, 2006c; 2006a: 57-76.
• Carstensen B, Kristensen JK, Ottosen P, Borch-Johnsen K.The Danish National Diabetes Register: trends in incidence, prevalence and mortality. Diabetologia, 2008; 51(12): 2187-96.
• Engelfriet PM, Hoogenveen RT, Boshuizen HC, Van Baal PH.To die with or from heart failure: a difference that counts. European Journal of Heart Failure, 2011a; 4(Apr; 13): 377-83.
• Feenstra TL, van Genugten ML, Hoogenveen RT, Wouters EF, Rutten-van Molken MP. The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands. Am J Respir Crit Care Med2001; 164(4): 590-6
• Hoogenveen RT, van Baal PH, Boshuizen HC, Feenstra TL. Dynamic effects of smoking cessation on disease incidence, mortality and quality of life: The role of time since cessation. Cost Eff Resour Alloc2008; 6: 1
• Hoogenveen RT, van Baal PH, Boshuizen HC. Chronic disease projections in heterogeneous ageing populations: approximating multi-state models of joint distributions by modelling marginal distributions. Math Med Biol2010; 27(1): 1-19
• Huiberdina L, Koek MD, Bruin A de, Gast F, Gevers E, Kardaun JWPF, et al.Short- and Long-Term Prognosis After Acute Myocardial Infarction in Men Versus Women. The American Journal of Cardiology, 2006; 98(8): 993-999.
• Jacobs-van der Bruggen MA, Bos G, Bemelmans WJ, Hoogenveen RT, Vijgen SM, Baan CA. Lifestyle interventions are cost-effective in people with different levels of diabetes risk: results from a modeling study. Diabetes Care2007a; 30(1): 128-34
• Jacobs-van der Bruggen MA, Engelfriet PM, Hoogenveen RT, van Baal PH, Struijs JN, Verschuren WM, Smit HA, Baan CA. Lipid-lowering treatment for all could substantially reduce the burden of macrovascular complications of diabetes patients in the Netherlands. Eur J Cardiovasc Prev Rehabil2008; 15(5): 521-5
• Kreijl CF van, Knaap AGAC, Busch MCM, Havelaar AH, Kramers PGN, Kromhout D, Leeuwen FXR van (eds), et al. Ons eten gemeten. Gezonde voeding en veilig voedsel in Nederland. RIVM-rapport nr. 270555007. Houten: Bohn Stafleu Van Loghum,2004.
• Lucht F van der, Polder JJ. Van gezond naar beter. Kernrapport van de Volksgezondheid Toekomst Verkenning 2010. Bilthoven: RIVM,2010.
• Mathers C, Vos T, Stevenson C.The burden of disease and injury in Australia (AIHW cat No PHE17). Canberra: AIHW, 1999.
• Stouthard MEA, Essink-Bot ML, Bonsel GJ, Barendregt J, Kramers PGN, Water HPA van de, et al.Wegingsfactoren voor ziekten in Nederland. Amsterdam: Instituut voor Sociale Geneeskunde AMC, 1997a.
• Stouthard MEA, Essink-Bot ML, Bonsel GJ, et al.Disability weights for diseases in the Netherlands. Rotterdam: Erasmus University, 1997b.
• Stouthard MEA, Essink-Bot ML, Bonsel GJ.Disability weights for diseases. A modified protocol and results for a Western European Region. On behalf of the Dutch Disability Weights Group. Eur J Public Health, 2000; 10: 24-30.
• Struijs JN, van Genugten ML, Evers SM, Ament AJ, Baan CA, van den Bos GA. Modeling the future burden of stroke in The Netherlands: impact of aging, smoking, and hypertension. Stroke2005; 36(8): 1648-55
• Tariq L, van den Berg M, Hoogenveen RT, van Baal PH. Cost-effectiveness of an opportunistic screening programme and brief intervention for excessive alcohol use in primary care. PLoS One2009a; 4(5): e5696
• van Baal PH, Polder JJ, de Wit GA, Hoogenveen RT, Feenstra TL, Boshuizen HC, Engelfriet PM, Brouwer WB. Lifetime medical costs of obesity: prevention no cure for increasing health expenditure. PLoS Med2008c; 5(2): e29
• van Baal PH, van den Berg M, Hoogenveen RT, Vijgen SM, Engelfriet PM. Cost-effectiveness of a low-calorie diet and orlistat for obese persons: modeling long-term health gains through prevention of obesity-related chronic diseases. Value Health2008b; 11(7): 1033-40
• Vijgen SM, van Baal PH, Hoogenveen RT, de Wit GA, Feenstra TL. Cost-effectiveness analyses of health promotion programs: a case study of smoking prevention and cessation among Dutch students. Health Education Research2008; 23(2): 310-8